Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel, Stable, and Well-Secreted Single-Chain Fc Forms of Programmed Death-1 Immune Checkpoint Inhibitor Efficiently Block PD-1/PD-L1 Interaction.

Human gene therapy·2026

Same author

Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder Cancer.

bioRxiv : the preprint server for biology·2026

Same author

The co-delivery of Programmed Death 1 ligands enhances and prolongs rAAV-mediated gene expression in pre-immunized mice.

Gene therapy·2026

Same author

CGT 4.0: a distant dream or inevitable future? Smart process automation is critical to make efficient scalability of CGT manufacturing a reality.

Frontiers in bioengineering and biotechnology·2025

Same author

Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model.

Frontiers in immunology·2024

Same author

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.

The Journal of urology·2024

Search research articles

Related Experiment Video

Updated: Apr 27, 2026

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

Development of Large-Scale Downstream Processing for Lentiviral Vectors.

Anniina J Valkama^1,2,3, Igor Oruetxebarria^1,2, Eevi M Lipponen^1,2

¹Kuopio Center for Gene and Cell Therapy, 70210 Kuopio, Finland.

Molecular Therapy. Methods & Clinical Development

|April 30, 2020

Summary

Scaling up lentiviral vector (LV) production is crucial for gene therapy. This study optimized LV purification and concentration, achieving high titers of 1.97 × 10^9 transducing units/mL for clinical applications.

Keywords:

anion exchange chromatography lentiviral vector process purification scale-up tangential flow filtration

More Related Videos

A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells

A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells

Published on: June 19, 2013

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

Related Experiment Videos

Last Updated: Apr 27, 2026

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells

A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells

Published on: June 19, 2013

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

Area of Science:

Biotechnology
Gene Therapy Manufacturing
Viral Vector Production

Background:

Lentiviral vectors (LVs) show promise for gene therapy but face manufacturing scale-up challenges.
Achieving high titers and purity for in vivo applications remains a significant hurdle.
Previous work established LV production scale-up using iCELLis 500 bioreactors.

Purpose of the Study:

To develop and optimize a downstream process for lentiviral vector purification and concentration.
To address the bottleneck in lentiviral vector purification scale-up, particularly the chromatography step.
To achieve clinical-grade lentiviral vector products with high infectious titers.

Main Methods:

Developed a downstream process involving clarification, buffer exchange, and concentration via tangential flow filtration (TFF).
Employed anion exchange chromatography (AEC) using single membrane technology for purification.
Optimized chromatography materials and conditions to overcome scale-up challenges.
Final formulation and concentration achieved through TFF.

Main Results:

Successfully scaled up lentiviral vector production and purification.
The optimized downstream process yielded a final infectious titer of 1.97 × 10⁹ transducing units (TU)/mL.
The process met titer and purity requirements for clinical use.

Conclusions:

The developed downstream process is effective for large-scale lentiviral vector manufacturing.
Optimized anion exchange chromatography is key to overcoming purification bottlenecks.
The high titer achieved supports the potential of this process for clinical gene therapy applications.